Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Vaccine
|
January 15, 2019
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up
Wen Chen, Yun Zhao, Xing Xie, et al.
Human Vaccines & Immunotherapeutics
|
July 17, 2025
Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants
Yulei He, Fengli Zhao, Xiao Yang, et al.
Pediatrics
|
August 20, 2014
Long-term study of a quadrivalent human papillomavirus vaccine
Daron Ferris, Rudiwilai Samakoses, Stan L Block, et al.
Blood Advances
|
November 16, 2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
Charles T Quinn, Richard T Wiedmann, Daniel Jarovsky, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
Shaomin Chen, Zhifang Ying, Yan Liu, et al.
The New England Journal of Medicine
|
February 20, 2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Vaccine
|
January 15, 2019
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up
Wen Chen, Yun Zhao, Xing Xie, et al.
Human Vaccines & Immunotherapeutics
|
July 17, 2025
Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants
Yulei He, Fengli Zhao, Xiao Yang, et al.
Pediatrics
|
August 20, 2014
Long-term study of a quadrivalent human papillomavirus vaccine
Daron Ferris, Rudiwilai Samakoses, Stan L Block, et al.
Blood Advances
|
November 16, 2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
Charles T Quinn, Richard T Wiedmann, Daniel Jarovsky, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
Shaomin Chen, Zhifang Ying, Yan Liu, et al.
The New England Journal of Medicine
|
February 20, 2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Page
of 2